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ABSTRACT 
Cocaine treatment caused a dose-related decrease in the 
microsomal monooxygenase and conjugative activities at one day 
following administration, with progressive recovery of the ac-
tivities over five days. Liver pathology showed midzonal necro-
sis with subsequent hepatocyte regeneration and resolution of 
necrotic areas. Serum glutamate-pyruvate transaminase activi-
ties were dramatically elevated in the early stages of toxicity. 
Norcocaine, an oxidative metabolite of cocaine, but not benzoyl-
ecgonine, a hydrolytic metabolite, produced a pattern of hepa-
totoxicity similar to cocaine. Both SKF 525-A and cobaltous 
chloride pretreatment decreased the hepatotoxic changes caused 
by cocaine and norcocaine. Phenobarbital pretreatment decreased 
the depression of monooxygenase activity with no effect on the 
increase in SGPT activity. Norcocaine-induced liver necrosis 
shifted from midzonal to periportal areas after phenobarbital-
pretreatment of the an'imal s. Pretreatment with 3-methyl cholan-
threne did not alter the midzonal necrosis caused by cocaine and 
norcocaine nor did it affect the changes in monooxygenase, con-
jugative, and SGPT activities. Both cocaine and norcocaine 
treatment produced a dose-dependent decrease in hepatic gluta-
thione concentration. Diethyl maleate pretreatment potentiated 
the cocaine- and norcocaine-induced changes in enzyme parameters, 
while cysteine pretreatment decreased the changes. It was con-
cluded that both cocaine and norcocaine are oxidatively metabo-
lized to a reactive metabolite, and glutathione conjugation may 
be an important pathway in detoxifying the metabolite. 
The possible relationship between cocaine metabolism and 
cocaine- and norcocaine-induced hepatotoxicity was investigated 
in rats and mice. The microsomal enzyme systems from both un-
treated rats and mice were capable of metabolizing cocaine to 
oxidative and hydrolytic products. The pattern of ~ vitro me-
tabolism of the two species showed quantitative rather than qual-
itative differences. Benzoylecgonine, a hydrolytic metabolite, 
was formed in greater amounts in rats than in mice, while nor-
cocaine, an oxidative metabolite, was produced in approximately 
equal quantities. The total percent of cocaine metabolized was 
only slightly greater in rats than mice because the latter pro-
duced greater quantities of unidentified metabolites. Rats pre-
treated with diethyl maleate developed cocaine- and norcocaine-
induced hepatotoxicity based on liver pathology and changes in 
the microsomal monooxygenase, conjugative, and serum glutamate-
pyruvate transaminase activities. It was concluded that even 
though both rats and mice can oxidatively metabolize cocaine and 
norcocaine to a hepatotoxic reactive intermediate, rats do not 
normally demonstrate toxicity because of a more favorable ratio 
of glutathione related detoxication relative to activation. 
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PART I 
ALTERATIONS IN MICROSOMAL AND SERUM ENZYME ACTIVITIES DURING 
COCAINE- AND NORCQCAINE-INDUCED LIVER NECROSIS IN MICE 
INTRODUCTION 
The illegal use of cocaine has greatly increased in the 
past ten years (Petersen, 1977) and is an acknowledged problem 
in the U.S.A. This has drawn considerable attention to its po-
tential toxicity. While the drug is not considered to be phys-
ically addictive, it has a high potential for abuse because of 
its stimulant action on the central nervous system (Byck and 
Van Dyke, 1977). Acute cocaine toxicity and death are related 
to its action on the central nervous system (Hardringe and 
Peterson, 1964; Hirschfelder and Bieter, 1932; Steinhaus and 
Tatum, 1950). While both cocaine and norcocaine are active on 
the central nervous system (Hawks' et al., 1974), recent reports 
describing cocaine-induced liver necrosis in mice have impli-
cated metabolites as the causative agents (Evans and Harbison, 
1978; Evans, 1979). 
In both man and animals, cocaine is rapidly and exten-
sively metabolized to hydrolytic (Fish and Wilson, 1969; 
Stewart et al., 1977; Taylor et al., 1976; Woods et al., 1951) 
and oxidative (Englert et al., 1976; Hawks et al., 1974; Lieghty 
and Fentiman, 1974; Misra et al., 1974; Ramos-Aliago and 
Chiriboga, 1970) metabolites which include: benzoylecgonine, 
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ecg~nine methyl ester, ecgonine, norcocaine, and benzoylnorecgo-
nine. Two major metabolic pathways catalyzed by the liver micro-
somal enzyme system are hydrolysis to benzoyl ecgonine and oxi-
dative demethylation to norcocaine (Jordan and Franklin, 1978; 
Leighty and Fentiman, 1974; Ramos-Aliago and Chiriboga, 1970). 
In addition to the major metabolic routes, several minor path-
ways have been proposed involving N-oxidation, ring hydroxyla-
tion and eooxidation (Evans and Harbison, 1978; Leighty and 
Fentiman, 1974; Nayak et a1., 1976). 
The liver cell necrosis observed in mice 24 hr after acute 
ip administration of cocaine (50 mg/tg) was midzonal in loca-
tion (Shuster et a1., 1977). This treatment resulted in an in-
crease in serum glutamic-oxa1oacetic transaminase activity and 
loss of glycogen, accumulation of fat, and cellular degeneration 
followed by regeneration in the liver. Similar changes devel-
oped following chronic cocaine administration at 10 and 20 mg/kg 
for 4 days. The pattern of toxicity was found to change by al-
tering the microsomal drug metabolizing capability of the liver. 
Phenobarbital pretreatment caused the cocaine-induced midzona1 
necrosis in uninduced animals (Shuster et a1., 1977; Jordan and 
Franklin, 1978) to shift to periportal areas (Evans and 
Harbison, 1978; Jordan and Franklin, 1978). In a preliminary 
report by Evans et a1. (1976), this shift was also accompanied 
by an increase in the number of mice dying between 3 hr and 7 
days ("de1ayed 1etha1ity"). Evans and Harbison (1978) also 
observed an 85% increase in covalent binding of cocaine to 
liver macromolecules with phenobarbital pretreatment, similar 
to the increased binding of acetaminophen by phenobarbital in-
duction (Jollow et al., 1973). 
Inhibition of metabolism by compounds that decrease cyto-
chrome P-450 content, such as cobaltous chloride (Tephly and 
Hibbeln, 1971) or inhibit cytochrome P-450 activity such as SKF 
525-A (Anders, 1971) can decrease the formation of toxic metab-
olites when produced by a monooxygenase enzyme (Brodie et al., 
1971; r1itchell et al ~, 1971; Zampagl ione et al., 1973). A de-
crease in the formation of a toxic metabolite has been observed 
for carbon tetrachloride and acetaminophen following cobaltous 
chloride pretreatment (Suarez and Bhonsle, 1976) and for bromo-
benzene following SKF 525-A pretreatment (Brodie et al., 1971; 
Mitchell et al., 1971; Zampaglione et al., 1973). In a recent 
communication by Smith et al. (1979), it was observed that SKF 
525-A pretreatment decreased the cocaine-"delayed lethality" in 
mice and the oxidative metabolism of cocaine in rats (Estevez 
et al., 1977). These observations, although not conclusive, 
implicate a metabolite(s) and not the parent compound as the 
hepatotoxic agent. 
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The process of altering the hepatotoxicity by modifying 
the activity of hepatic drug-metabolizing enzymes has been shown 
for a number of compounds: 2-acetylaminofluorene, carbon 
tetrachloride, bromobenzene, acetaminophen, furosemide, 
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iso~iazid, parathion, and thioacetamide. Phenobarbital pre-
treatment can increase the hepatotoxicity for certain compounds 
which may involve a reactive intermediate, such as acetaminophen 
in mice (Mitchell et al., 1973) and bromobenzene in rats 
(Zampaglione et al., 1973). Alternatively, it may have little 
or no effect, such as acetaminophen in hamsters (Potter et al., 
1974) or possibly even decrease the toxicity by increasing al-
ternate, nontoxic metabolic pathways (Jollow and Smith, 1977). 
Therefore, the development of toxicity is often determined by a 
balance between formation of reactive metabolites and their in-
activation by processes such as conjugation. 
By altering the availability of hepatic glutathione (GSH), 
the potential hepatotoxicity of metabolically generated electro-
philic reactive intermediates may be affected. These intermed-
iates can conjugate with GSH rather than bind to cellular mac-
romolecules. Studies with acetaminophen have shown that deple-
tion of hepatic GSH by diethyl maleate pretreatment potentiated 
the hepatic necrosis and covalent binding (Mitchell et al., 
1973). Diethyl maleate pretreatment increased the IIdelayed 
lethality" and necrosis caused by cocaine in phenobarbita1-
pretreated mice and produced necrosis in uninduced mice which 
normally did not show necrosis, while cysteine pretreatment de-
creased the necrosis (Evans and Harbison, 1978). These authors 
postulated that metabolic activation of cocaine to an N-oxide, 
which has subsequently been identified as a metabolite by Evans 
(1979) was responsible for the cocaine-induced hepatotoxicity. 
The mechanism of N-oxide interaction with cellular macromole-
cules or its detoxification by GSH was not elucidated. 
At present, very little is known about the effects of 
cocaine and its metabolites on the liver microsomal enzymes. 
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If cocaine is activated by metabolism, then alterations in the 
drug metabolizing capability caused either by cocaine itself or 
other agents may affect the pattern of toxicity as manifest by 
hepatbcyte necrosis and changes in the microsomal and serum 
enzymes. Benzoylecgonine and benzoylnorecgonine, which are both 
hydrolytic metabolites of cocaine, were not hepatotoxic 
(Shuster et al 0' 1977; Jordan and Franklin, 1978), and esterase 
inhibitors enhanced the hepatotoxicity of cocaine according to 
a communication by Freeman and Harbison (1978). Norcocaine, an 
oxidative metabolite, has recently been reported to produce 
hepatotoxicity in phenobarbital-induced mice similar to cocaine 
(Evans, 1979). 
The following study examined the changes in the liver 
microsomal and serum enzymes which occur during cocaine and nor-
cocaine hepatotoxicity. The major liver metabolites of cocaine 
were also examined for their hepatotoxic effects. Because cyto-
chrome P-450 was postulated as the site for metabolic activation 
of cocaine, the xenobiotic metabolizing capacity of the micro-
somal enzymes were altered by inducers and inhibitors, and the 




Animals and Treatment 
All animals used for this study were male outbred albino 
mice, CFl strain, obtained from Charles River's Laboratory 
(Wilm)ngton, Massachusetts). Animals 7 to 8 weeks old (23-27 g) 
or 8 to 9 weeks old (25-30 g) were housed under controlled con-
ditions with free access to water and food (S/L custom lab diet, 
G4.5, Simonsen Laboratories, Inc., Gilroy, California) at least 
one week prior to use. Unless otherwise indicated, all drugs 
were dissolved in saline, filtered through a 0.2 ~m Millipore 
filter and administered ip in a constant volume (0.1 ml/10 g). 
Pretreated animals received phenobarbital (80 mg/kg) for 4 days, 
3-methylcholanthrene (20 mg/kg) in corn oil for 3 days or co-
baltous chloride (60 mg/kg) for 2 days. Diethyl maleate 
(0.6 ml/kg) in corn oil, cysteine (150 mg/kg), or 2-diethylamin-
oethyl-2,2-diphenylvalerate:HCl (SKF 525-A) at 100 mg/kg were 
administered 30 min, 5 min, and 1 hr prior to cocaine or norco-
caine, respectively. 
Preparation of Microsomes and 
Enzymatic Analysis 
Livers from 10 to 12 mice for each treatment group were 
pooled, and hepatic microsomes were prepared as described by 
Fra~klin and Estabrook (1971), with minor modifications. Ani-
mals were not starved prior to sacrificing. The protein concen-
tration was determined by the Biuret method (Gornall et al., 
1949), with bovine serum albumin as the reference standard. 
Microsomes in 50 mM Tris-chloride, pH 7.4, containing 0.25 M 
sucrose were adjusted to 30 mg/ml and either used immediately or 
stored at -20 0 C and analyzed within 24 hr. 
All spectrophotometric determinations of microsomes were 
performed with a temperature-regulated (25 0 C) Aminco DW-2 spec-
trophotometer at 2 mg of microsomal protein per m1 of assay mix-
ture. The cytochrome P-450 content was measured by the method 
described by Omura and Sato (1964) using an extinction coef-
ficient of 91 mM-1cm-1 for the reduced cytochrome P-450-carbon 
monoxide complex. The maximum rate of norbenzphetamine-
cytochrome P-450 metabolic intermediate (MI) complex formation 
was determined according to the procedure of Franklin (1974a) 
using an extinction coefficient of 65 mM-lcm- l (Franklin" 
1974b). The assay mixture contained 0.1 mM norbenzphetamine, 
and the reaction was' initiated by the addition of NADPH to a 
final concentration of 0.4 mM. NADPH-cytochrome £ reductase 
was measured by the procedure described by Masters et ale 
(1971). The dealkylation of ethylmorphine was determined by 
the production of formaldehyde (Nash, 1953) and of p-nitro-
anisole by the formation of p-nitrophenol (Netter and Siedel, 
1964). Uridine 51 -diphospho (UDP)-glucuronyl transferase 
9 
actiyity was measured by the rate of conjugation of p-nitro-
phenol with glucuronic acid in SO mM Tris-chloride buffer, pH 
7.8S, containing lSO mM KC1, 10 mM MgC12' 100 ~M p-nitrophenol, 
and 2.5 mM UDP-glucuronic acid (Franklin, 1974c). Glucuronide 
conjugation was monitored in the presence and absence of a low 
concentration (O.OS%) of a nonionic detergent (Triton X-100). 
The rate of glucuronide formation in the absence of detergent 
gives an indication of the functional glucuronyl transferase, 
whi1e'that seen in the presence of detergent provides an indi-
cation of the total (active and latent) enzyme present in the 
microsomal membrane (Lueders and Kuff, 1967). Serum glutamate-
pyruvate transaminase (SGPT) was measured according to the 
method of Wroblewski and LaDue (19S6), as revised by Henry 
et ala (1960), and subsequently modified and reported by Cal-
biochem (La Jolla, California). Approximately 80 mice were in-
jected ip with filtered cocaine (40 mg/kg) or saline. At var-
ious times, serum was obtained from S or 6 cocaine- and saline-
treated animals by cardiac puncture following ether anesthesia. 
Whole blood (O.S-l.O m1) was allowed to coagulate for 20 min 
and then centrifuged (3S00 RPM) for lS min to obtain the serum. 
Serum samples were immediately frozen (-2S0 C) and SGPT activ-
ity measured within 2 days. The reduced GSH concentration in 
the liver was determined by the method described by Hissin and 
Hilf (1976) using o-phtha1aldehyde as the fluorescent reagent. 
10 




At least two animals at each treatment were randomly 
selected for histopathologic examination of the livers. Liver 
tissue was obtained from animals sacrificed by decapitation and 
immediately sectioned and placed in 10% neutral buffered forma-
lin. From each liver, several paraffin blocks were prepared, 
each representing a differnt lobe. Hematoxylin and eosin (H&E), 
Masson trichrome, periodic acid-Schiff (PAS), Von Kossa, iron, 
or reticulin stains were performed on approximately 2.5 cm2 of 
liver tissue (Luna, 1968). Livers were examined with special 
reference to extent and location of hepatocyte necrosis, dys-
trophic calcification and giant cells, regeneration, inflamma-
tion, cholestasis, fibrosis, fat, and glycogen content. Nec-
rosis was considered to be present when nuclear degeneration or 
nuclear absence was observed together with cytoplasmic eosino-
philia. The extent of necrosis was assessed as the percent of 
the lobule diffusely involved. The zonal location of the nec-
rosis was also determined. Regenerative activity was evaluated 
by the presence of an increased number of bi- and multi-
nucleated hepatocytes together with increased numbers of mitotic 
figures. Regenerative activity was judged to be increased if 
there were mitotic figures in more than 50% of high power 
fields examined. Inflammation was assessed by the appearance of 
acute and chronic inflammatory cells around necrotic areas and 
focal chronic inflammation apart from these areas. 
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Electron microscopy was performed on livers from mice at 
15 and 30 min and 24 hr after receiving a single injection of 
cocaine (40 mg/kg) or saline. The liver tissues were minced 
into less than 1 cubic mm blocks and were fixed in phosphate 
buffered formaldehyde gluteraldehyde fixative (Karnovsky, 1965). 
After 2 to 4 hr fixation at room temperature, the specimens were 
washe~ in 0.1 M phosphate buffer and post-fixed in 1% aqueous 
osmium tetroxide solution (Bahr, 1954) for 1 hr. Subsequently, 
they were washed and dehydrated in ethanol using a Reichert EM 
Tissue Processor (American Optical, Buffalo, New York). They 
were infiltrated and embedded in Spurr resin (Spurr, 1969). The 
sections were cut on a lKB Ultramicrotome III (lKB Instruments, 
Inc., Rockville, Maryland) at 600-700 angstroms thickness, 
stained with uranyl acetate (Watson, 1958) and lead citrate 
(Reynolds, 1963), and examined in a JEOl 100-eX transmission 
electron microscope (JEOl, U.S.A., Inc., Medord, Massachusetts). 
Chemicals 
NADPH, cytochrome £ (Type VI) UDP-glucuronic acid, sodium 
isocitrate, isocitrate dehydrogenase (Type VI), l-cysteine, bo-
vine serum albumin, 3-methylcholanthrene, GSH, and o-phthalade-
hyde were obtained from Sigma Chemical Co. (St. louis, Missouri): 
phenobarbital and ethylmorphine were obtained from Mallinckrodt 
Chemical Works (St. louis, Missouri); SKF 525-A:HCl from Smith 
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Kline & French Laboratories (Philadelphia, Pennsylvania); nor-
benzphetamine:HCl (N-benzyl-a-methylphenylethylamine:HC1) from 
Upjohn Co. (Kalamazoo, Michigan); p-nitroanisole and Triton X-
100 from J.T. Baker Chemical Co. (Phillipsburg, New Jersey); 
diethyl maleate (80%) from Aldrich Chemical Co. (Milwaukee, 
Wisconsin); and p-nitrophenol from Eastman Organic Chemicals 
(Rochester, New York). SGPT stat-packs were purchased from Cal 
Biochem (La Jolla, California). Cocaine:HCl was obtained from 
Merck and Co., Inc. (Rahway, New Jersey), and norcocaine and 
benzoy1ecgonine were prepared as described by Jordan and 
Franklin (1979). 
RESULTS 
The dose- and time-related changes in microsomal drug 
metabolizing parameters caused by cocaine are seen in Table 1. 
At one day following treatment, cocaine caused a dose-dependent 
decre~se in the mixed-function oxidase parameters, exemplified 
by p-nitroanisole and ethylmorphine demethylation and norbenz-
phetamine MI complex formation. The enzymatic activities were 
decreased more than was cytochrome P-450 for each dose. For 
example, cocaine at 80 mg/kg decreased cytochrome P-450 content 
by approximately 50%, but p-nitroanisole and ethylmorphine de-
methylation and norbenzphetamine MI complex formation were de-
creased by 70 to 80%. At this dose, NADPH cytochrome £ reduc-
tase was also decreased, but at 20 and 40 mg/kg this change was 
not observed. After one day, conjugative activity, represented 
by UDP-glucuronyl transferase, showed an increase, with the in-
crease being dependent on the dose of cocaine. At the higher 
doses, this activity was activated over two-fold. The total 
transferase activity was decreased in a dose-dependent manner. 
After 3 to 5 days following treatment, the drug metabolizing 
parameters showed progressive recovery. In most cases, espe-
ciallyafterthe lower doses (20 and 40 mg/kg), the values re-



















































































































































































































































































































































































































































































































































































































































for -the various enzymes could be related to different turnover 
rates for these integral membrane proteins. 
16 
The mice also developed liver necrosis, which was depen-
dent upon the dose of cocaine. Diffuse necrosis was well de-
veloped 24 hr subsequent to cocaine administration at the higher 
doses (40, 60, and 80 mg/kg). Figures 1 through 6 demonstrate 
the time-dependent changes in liver morphology for 6 sequential 
days following cocaine administration at 40 mg/kg. The extent 
and location of the necrosis is summarized in Table 2, with 
days 1 and 2 showing the most severe changes at the higher 
doses. In general, liver injury was midzonal at intermediate 
doses (40 mg/kg) (Figures 1 and 2) or both mid- and central 
zonal, in some cases, at 60 and 80 mg/kg where necrosis was 
most severe. liver necrosis at higher doses (40 to 80 mg/kg) 
always occurred diffusely within the mid- or central zones of 
the liver lobule. However, in two isolated cases (40 mg/kg, 
day 2; 60 mg/kg, day 1), no liver necrosis was observed .. Ne-
crotic areas gradually resolved concomitant with regenerative 
activity, which became apparent by 24 hr and continued through-
out the time period studied (6 days). Six days after cocaine 
injection, evidence of necrosis was greatly diminished, as seen 
by comparing Figures 1 and 6. The progressive recovery of the 
liver from cocaine-induced damage was consistent with the grad-
ual return of the microsomal enzyme activity to approximately 
control values after 5 days. 
FIGURE 1 
Cocaine-induced hepatocyte necrosis in mice. One day 
after cocaine (40 mg/kg) injection. Predominantly midzonal 
necrosis is shown. The lighter staining cells, some with pyk-
notic nuclei, are necrotic cells. Hepatocytes around portal 
tracts (top) and central veins (bottom center and right) are 





Cocaine-induced hepatocyte necrosis in mice. Two days 
after cocaine (40 mg/kg) injection. Midzonal necrosis is shown 
with acute and chronic inflammation with some cells showing 
fatty change or hydropic degeneration. Mitotic figures can be 
found in most fields (left center), indicating regenerative 
activity. Periportal areas (upper left) and central areas 




Cocaine-induced hepatocyte necrosis in mice. Three days 
after cocaine (40 mg/kg) injection. The midzonal areas of 
necrosis show parenchymal disorganization with necrotic hepato-
cytes and acute and chronic inflammation. Darker staining areas 





Cocaine-induced hepatocyte necrosis in mice. Four days 
after cocaine (40 mg/kg) injection. Resolution of liver cell 
necrosis is shown with surrounding mitotic figures (left center 




Cocaine-induced hepatocyte necrosis in mice. Five days 
after cocaine (40 mg/kg) injection. Resolution of liver cell 
necrosis is shown with prominent pericentral dystrophic calci-





Cocaine-induced hepatocyte necrosis in mice. Six days 
after cocaine (40 mg/kg) injection. Almost complete resolution 
of liver cell necrosis is shown with occasional dystrophic cal-
cification and giant cell formation (center). Heptocellular un-
rest is still evident. Portal tract is present in the upper 



















































































































































































































































































































































































































































































. Surrounding the necrotic areas, mild fatty change could 
be seen for 2 days following injection (Figure 2). Generali2ed 
inflammation, cholestasis and fibrosis were absent. PAS staiDs 
of representative sections (40, 60, 80 mg/kg; days 2, 4, 6) 
showed mid- and central zonal glycogen depletion and retention 
of periportal glycogen (Figure 7). 
Previously necrotic areas were replaced with calcifica-
tion, giant cells, and chronic inflammation (Figure 8). Dys-
trophic calcification and giant cell formation were generally 
prominent on days 3 through 6 after injection and were located 
at the periphery of the necrotic areas (Figure 3). As resolu-
tion of the damaged tissue progressed and normal liver archi-
tecture returned, the calcifications and surrounding giant cells 
also resolved. 
Electron micrographs 15 min. after cocaine at 40 mg/kg 
(Figure 9) showed numerous fat vacuoles (FV) and dil~ted smooth 
endoplasmic reticulum (SER)* Mitochondrial swelling, ribosomal 
detachment, and disruption of the rough endoplasmic reticulum 
(RER) were not seen. Cytoplasmic blebs and changes in bile 
canaliculus were also absent. At 30 min after cocaine, addi-
tional degenerative changes had occurred (Figure 10). Aggre-
gation of nuclear chromatin became apparent. Sinusoids (SIN) 
and intercellular spaces (ICS) were widened, but spaces of Disse 
(SO) remained intact, as did mitochondria. Prominent fat vacu-
oles were present as seen at 15 min, however, lysosomes (L) 
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FIGURE 7 
Cocaine-induced hepatocyte necrosis in mice. Two days 
after cocaine (60 mg/kg) injection. Glycogen depletion corres-
ponding in location to midzonal necrosis seen on H & E is 
shown. A portal tract is present in the bottom right field 




Cocaine-induced hepatocyte necrosis in mice. Four days 
after cocaine (40 mg/kg) injection. An area of dystrophic cal-
cification and chronic inflammation with giant cell formation 
is shown. While this feature was not seen in all livers, it 




Cocaine-induced subcellular changes in mice. Electron 
micrograph (magnification 71,500 X) showinq fat vacuoles (FV) 
and dilated smooth endoplasmic reticulum (SER). Mitochondria 
(M), when compared to controls, were unchanged (15 min after 






Cocaine-induced subcellular changes in mice. Electron 
micrograph (magnification 9075 X) showing dilated sinusoids 
(SIN) and intercellular spaces (ICS). Spaces of Oisse (SO) re-
main intact, as do rough endoplasmic reticulum (RER) and mito-
chondria (M). Lysosomes (L) containing membrane-like material 
are dilated and appear more prominent (inset). Red Blood cell 
(RBC), nucleus (N) (30 min after cocaine, 40 mg/kg). 
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containing membrane-like material were now observed in areas of 
injury (inset Figure 10). RER remained unchanged with no e~i­
dence of ribosomal detachment. 
The subcellular changes seen by electron microscopy in-
volved mainly fat vacuolization and dilated SER, which could be 
seen in both central and midzonal locations in contrast to 
light microscopic findings of early injury (24 hr) which were 
confined to midzonal locations. Although not shown here, elec-
tron micrographs taken at 24 hr after cocaine showed complete 
obliteration of ultrastructural detail in mid- and central re-
g;ons. 
The changes in hepatic microsomal enzyme activities at 8, 
16, and 24 hr following cocaine and norcocaine are given in 
Table 3. Both cocaine and norcocaine produced similar changes 
over the time course. Cytochrome P-450 content was decreased by 
approximately 25% as early as 8 hr after cocaine or .norcocaine 
and remained depressed throughout the study. Only small in-
creases were observed in NADPH cytochrome £ reductase activity, 
which may possibly be attributed to changes in microsomal mem-
brane. The increased UDP-glucuronyl transferase activity was 
more obvious, with both cocaine and norcocaine causing an acti-
vation of some latent enzyme by 8 hr, which remained activated 
over the time course. Only slight decreases in the total enzy-
matic activity, which was measured in the presence of detergent, 






























































































































































































































































































































































































































































































p-n5troanisole O-demethylation and norbenzphetamine MI complex 
formation, was decreased in a manner similar to cytochrome P-450, 
although this was not apparent for p-nitroanisole O-demethyla-
tion until 16 hr after treatment. In general, both cocaine and 
-
norcocaine caused a rapid alteration (as early as 8 hr) in mi-
crosoma1 enzyme activity, and the severity of change was approx-
imately the same for all parameters. Contrary to the changes 
seen for cocaine and norcocaine (Tables 1 and 3), benzoylecgo-
nine did not cause major decreases in any of the microsomal 
parameters at either one or five days following treatment. 
There was often some increase in activity but there was not ob-
vious dose dependency (Table 4). 
The time course changes in SGPT activity following norco-
caine and benzoyl ecgonine were compared with those for cocaine 
(Figure 11). Norcocaine and coc&ine caused a similar pattern of 
change, with norcocaine showing a slightly more rapid increase 
in the first 8 hr. The maximum increase of approximately 250-
fold over controls occurred at about 16 hr after treatment and 
gradually returned to control values by 72 hr. Benzoylecgonine 
treatment did not cause any change in SGPT activity_ These 
changes in SGPT activity by cocaine and norcocaine and the lack 
of change by benzoyl ecgonine were consistent with the altera-
tions in the microsomal enzyme parameters seen above. 
As with cocaine, norcocaine caused a dose-related change 

































































































































































































































































































































































































































































































































Changes in SGPT activity following acute ip administra-
tion of cocaine ( .. - ... ), norcocaine (0--0), and benzoy1ec-
gonine (tt 4t) at 40 mg/kg. Serum was taken from 5 or 6 mice 
at each t-ime after treatment, and values are expressed as the 
mean + SEM. Animals receiving saline had a mean activity 
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45 
5) •. Cytochrome P-450 and p-nitroanisole O-demethylation were 
decreased almost identically by cocaine and norcocaine. Co-
caine and norcocaine at 40 mg/kg decreased both values by only 
10%, but at 60 mg/kg they were decreased by approximately 40% 
to 50%. UDP-glucuronyl transferase activity was only increased 
by 5% at 40 mg/kg but by 60% at 60 mg/kg for both cocaine and 
norcocaine. The SGPT activity was dramatically increased (200-
fold at 60 mg/kg and 50- to 60-fold at 40 mg/kg) by cocaine and 
norcocaine. Animals treated with inhibitors of cytochrome P-
450 affected the microsomal drug metabolizing enzymes. Treat-
ment with SKF 525-A only slightly altered cytochrome P-450 con-
centrations but greatly decreased the mixed-function oxidase 
activity, as seen by p-nitroanisole O-demethylation (approxi-
mately 50%). The SGPT activity was increased 7-fold over un-
treated ani~als by SKF 525-A treatment. Cobaltous chloride 
(CoC1 2), like SKF 525-A, caused a slight increase in UDP-
glucuronyl transferase activity. However, the cytochrome 
P-450 concentration was decreased by 50%, with a similar de-
crease in p-nitroanisole O-demethylation. SGPT activity was 
unaffected by this pretreatment. 
In general, SKF 525-A and CoC12 pretreatment decreased 
the hepatotoxic effects caused by cocaine and norcocaine. The 
marked increase in SGPT activity was completely prevented by 
SKF 525-A, since values were not increased above those of the 


























































































































































































































































































































































































































































































































































































































































































































































SGPT activity, although not completely. The depression in the 
monooxygenase parameters by cocaine and norcocaine was either 
partially or completely prevented by SKF 525-A or CoC1 2 pre-
treatment, with only a few exceptions. Thus, for example, the 
cocaine- (60 mg/kg) induced decrease (50%) in cytochrome P-450 
content and p-nitroanisole O-demethylation was completely 
blocked by CoC1 2 pretreatment and nearly blocked by SKF 525-A. 
The activation of UDP-glucuronyl transferase by cocaine and nor-
cocaine was prevented by SKF 525-A but not by CoC1 2. Similarly, 
the decrease of the total activity of transferase was, in gen-
eral, lessened by SKF 525-A and CoC'2. 
Phenobarbital and 3-methylcholanthrene induction produced 
the characteristic changes in the microsomal enzyme activities 
(Table 6). Phenobarbital caused increases in NADPH cytochrome 
c reductase and the monooxygenase parameters (represented by 
cytochrome P-450, p-nitroanisole and ethylmorphine demethyla-
tion, and norbenzphetamine MI complex formation), but UDP-
glucuronyl transferase was apprently unaffected by this treat-
ment. Induction by 3-methylcholanthrene produced less in-
crease, if any, than phenobarbital in the enzymatic activities. 
The increased cytochrome P-450 was of the type that forms a re-
duced cytochrome P-450 carbon monoxide ligand interaction ab-
sorbing maximally at 448 nm (cytochrome P-448). 
The pattern of cocaine and norcocaine hepatotoxicity was 
altered by phenobarbital induction and, to a much lesser ex-
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coca~ne or norcocaine, the changes in microsomal parameters were 
reduced by phenobarbital pretreatment. The decrease in cyto-
chrome P-450 content was only 10% with phenobarbital induction 
compared with 25% in uninduced microsomes. Similarly, the 17% 
decrease in p-nitroanisole O-demethylation was reduced to 3%, 
and the 35% decrease in ethylmorphine N-demethylation was not 
observed with phenobarbital induction. Norbenzphetamine MI 
complex formation without induction was depressed by 50% and 
with phenobarbital induction no decrease was observed. The 50% 
activation in UDP-glucuronyl transferase was reduced to only 
10 to 30% by phenobarbital pretreatment, and the loss of total 
activity was reduced to 5%. The cocaine-induced depression of 
the monooxygenase parameters at 24 hr was nearly identical with 
or wtthout 3-methy1cholanthrene pretreatment, the changes being 
23%, 20%, 38%, and 50% decreases in cytochrome P-450, p-nitro-
anisole or ethylmorphine demethy1ation, and norbenzphetamine MI 
complex formation, respectively. However, 3-methylcholanthrene 
induction slightly reduced the norcocaine depression of the mon-
ooxygenase parameters. Cytochrome P-450 depression was reduced 
from 26% to 16%, p-nitroaniso1e 0-demethy1ation from 17% to 
9%, ethylmorphine N-demethy1ation from 33% to 14%, and norbenz-
phetamine MI complex formation from 59% to 14%. Cocaine- and 
norcocaine-induced changes in UDP-glucurony1 transferase activ-
ity either in the presence or absence of detergent were not 
altered by 3-methy1cholanthrene pretreatment. Changes in the 
microsomal parameters caused by cocaine either with or without 
induction were similar after 5 days, where values had returned 
to approximately those without any treatment. The loss of in-
duction and a decrease in toxicity accounted for the return to 
control values. 
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The effects of phenobarbital and 3-methylcholanthrene in-
duction on norcocaine-induced hepatic necrosis are seen in 
Figures 12A-12C. Norcocaine produced diffuse midzonal hepato-
cyte necrosis (Figure 12A) identical to cocaine (Shuster et 
al., 1977). The predominantly midzonal lesion was shifted to 
periportal regions of the liver lobule by phenobarbital pre-
treatment (Figure l2B). A similar change from midzonal to 
periportal necrosis occurred with cocaine in moving from un-
treated mice (Shuster et al., 1977) to phenobarbital-pretreated 
mice (Evans and Harbison, 1978). Induction by 3-methylcholan-
threne did not alter the pattern of necrosis and produced mid-
zonal necrosis similar to norcocaine alone (Figure 12C). 
The effects of phenobarbital and 3-methylcholanthrene on 
the time course change in SGPT activity by cocaine at 40 mg/kg 
is seen in Figure 13. Cocaine caused a similar increase in 
SGPTactivity following pretreatment with either inducing agent. 
Both produced approximately the same increase with a maximum 
at about 16 hr after cocaine. The slightly elevated SGPT ac-
tivity at the earliest time point (zero hr) after phenobarbital 
pretreatment might be attributable to a more rapid release of 
51 
FIGURE 12 
Norcocaine-induced hepatocyte necrosis in mice. Norco-
caine (40 mg/kg) was acutely administered ip to untreated mice 
(Panel A), or to phenobarbital- (Panel B), and 3-methylcholan-
thren~- (Panel C) pretreated mice 24 hr after the last pre-
treatment injection. Sections of liver tissue were prepared as 






Changes in SGPT activity following acute ip administra-
tion of cocaine (40 mg/kg) in phenobarbital ((}---{)) and 3-
methylcholanthrene (~--~) pretreated mice. Saline was ad-
ministered to untreated mice (4t 4t). Serum was taken from 
5 or 6 mice at each time after acute treatment and values are 
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GPT into the serum in phenobarbital animals during the 3 to 5 
min delay in serum sampling by the cardiac puncture procedur·e. 
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The effects of pretreatment with diethyl maleate, which 
depletes hepatic GSH, or cysteine, a precursor of GSH, on co-
caine and norcocaine hepatotoxicity were examined (Table 7). 
Neither diethyl maleate or cysteine caused a significant change 
in SGPT activity or in the microsomal parameters, except pos-
sibly a slight increase in NADPH cytochrome ~ reductase by 
diethyl maleate and a slight increase in total UDP-glucuronyl 
transferase activity by cysteine. Diethyl maleate intensified 
the effects of cocaine and norcocaine on microsomal enzymes 
and SGPT activity. Cytochrome P-450 concentration, which was 
normally depressed 25 and 14% by cocaine and norcocaine, re-
spectively, was further depressed by diethyl maleate pretreat-
ment to 42% and 40% of control for cocaine and norcocaine, re-
spectively. A similar decrease was seen for ~-nitroanisole 0-
demethylation, where the activity dropped from 21% to 42% of 
control for cocaine and from 16% to 47% of control for norco-
caine. The UDP-glucuronyl transferase activation by cocaine 
was further enhanced by diethyl maleate, and the decrease in 
total activity was further decreased, although not dramatically. 
Particularly striking was the cocaine- and norcocaine-induced 
release of GPT after diethyl maleate pretreatment. Both cocaine 
and norcocaine produced about a l50-fold increase in activity, 
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contrast to the potentiation of cocaine and norcocaine toxicity 
caused by diethyl maleate, cysteine pretreatment lessened the 
changes. This is best seen by the smaller increase in SGPT ac-
tivity of about 45-fold for cocaine or norcocaine with cysteine 
pretreatment compared with l50-fold without cysteine. The de-
creases in cytochrome P-450 and p-nitroanisole O-demethylation 
were partially blocked by cysteine. The activation of latent 
UDP-glucuronyl transferase was lessened, and the total activity 
was unchanged. The slight increase in NADPH cytochrome £ reduc-
tase by cocaine and norcocaine (Table 7), and occasionally for 
cocaine (Tables 3, 5, and 6), was not apparent after diethyl 
maleate or cysteine pretreatment. In general, diethyl maleate 
potentiated the changes in the enzymatic activities caused by 
cocaine and norcocaine, while cysteine antagonized these ef-
fects. 
Cocaine and norcocaine caused a dose- and time-related de-
crease in hepatic GSH concentrations (Figure 14). The patterns 
of depression at 60 mg/kg were nearly identical for the 2 drugs 
(Figure l4A), with a maximum depression of approximately 50% 
occurring at 4 hr after treatment. Neither saline nor benzoyl-
ecgonine at 60 mg/kg produced a change in GSH levels. The 
rapid and marked decrease caused by diethyl maleate was con-
sistent with the changes observed in rat livers by Boyland and 
Chasseaud (1970). While cocaine and norcocaine caused a sub-
stantial decrease in GSH levels, the change developed much 
FIGURE 14 
The time course changes in hepatic GSH concentrations in 
mice following ip administration of cocaine ((}---()), norco-
ca-j ne (A.---A.), and benzoyl ecgoni ne (~) at 60 mg in sa-
line (e .); and diethyl maleate (e---.) at 0.6 ml/kg in 
corn oil are seen in Panel A. Diethyl maleate was used as a 
positive control for GSH depletion. The dose-related changes 
60 
in hepatic GSH concentration at 4 hr after treatment with co-
caine ()---{)) and norcocaine (~ ~) are seen in Panel B. 
GSH concentrations were determined as described in "Methods" 
from livers of at least 4 mice for each treatment dose and time. 
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slower than the change with diethyl maleate. The maximum de-
pletion of GSH by cocaine and norcocaine was not as great as 
diethyl maleate, even at high doses. Both cocaine and norco-
caine produced a similar dose-dependent decrease of hepatic GSH 
at 4 hr after treatment (Figure 148). 
DISCUSSION 
The cocaine-induced hepatotoxicity that was observed in 
mice (Evans and Harbison, 1978; Shuster et al., 1977) has been 
confirmed. In addition to these earlier reports, this investi-
gation showed that the location and extent of liver necrosis 
could be predicted, depending on the dosage and length of time 
following acute cocaine administration (Table 2). Necrosis ob-
served by light microscopy at lower dosage (40 mg/kg) was mid-
zonal and at higher dosages (60 and 80 mg/kg), mid- and central 
zonal (Figures 1-8). The area of necrosis was unusual for a 
cytochrom~ P-450-activated hepatotoxin, because most such 
agents cause necrosis in the centrilobular region (Slater, 
1966; Koch-Weser, 1953). 
This paper also examines the adverse effects of cocaine 
and its metabolites on the liver microsomal enzymes which ,have 
not been previously investigated. Cocaine is metabolized pre-
dominantly by hydrolytic and oxidative pathways in the liver. 
The balance in metabolism between these routes is an important 
determinant of the pharmacological and toxicological action of 
cocaine. Benzoylecgonine, a hydrolysis product, is pharmaco-
logically inactive (Misra et al., 1975) and did not produce 
64 
hep~totoxic effects at doses si~ilar to those at which cocaine 
caused hepatotoxicity, based on changes in the microsomal and 
serum enzymatic activities (Table 4 and Figure 11). Norcocaine, 
an oxidatively demethylated product, is pharmacologically as 
active as cocaine (Hawks et al., 1974) and produced changes in 
the hepatic microsomal and serum enzymes equivalent to cocaine 
(Figure 11, Tables 3 and 5). 
Mixed-function oxidase activity was necessary for cocaine 
and also norcocaine to produce hepatotoxic effects, because 
SKF 525-A or cobaltous chloride pretreatment decreased their 
hepatotoxicity (Table 3). The metabolic activation of cocaine 
to a reactive N-oxide intermediate has been postulated by Evans 
and Harbison (1976, 1978) and Evans (1979). The present study 
does not eliminate this mechanism of cocaine-induced hepatotox-
icity, but other reactive metabol~tes must also be considered, 
because cocaine is only partially converted to norcocaine in 
the liver (Englert et a1., 1976; Estevez et a1., 1977; Leighty 
and Fentiman, 1974; Ramos-A1iago and Chiriboga, 1970), yet both 
are approximately equipotent hepatotoxins at the same dose. 
Inactivation of a reactive metabolite would also be de-
pendent on detoxification pathways. GSH concentrations were 
important in protecting the liver cells from the toxic effects 
of cocaine and norcocaine, which could involve conjugation of a 
reactive metabolite with GSH directly or by maintaining the 
cellular integrity by some unknown mechanism. Cysteine 
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pretreatment was capable of decreasing the hepatotoxicity, while 
diethyl maleate pretreatment potentiated the effects of cocaine 
and norcocaine. Consistent with the biochemical changes, GSH 
levels in the liver were dose-dependently decreased by cocaine 
and norcocaine treatment. 
Electron microscopy performed very early after cocaine 
administration revealed ultrastructural changes. Accumulation 
of fat in vacuoles was a prominent early (15 min) chang~ (Fig-
ure 9) which was particularly interesting in view of the absence 
of significant fatty change by light microscopy. Dilation of 
the smooth endoplasmic reticulum was also present. Changes 30 
min after cocaine administration became more marked, with evi-
dence of more extensive membrane damage (Figure 10). Lysosomes 
containing membrane fragments and extracellular alterations in 
the form of intercellular edema and sinusoidal dilation became 
apparent. 
The changes observed in the endoplasmic reticulum are par-
ticularly important, because cocaine is metabolized in the liver 
mainly by enzymes located in the endoplasmic reticulum. The 
morphologic changes in the endoplasmic reticulum and alterations 
of microsomal UDP-glucuronyl transferase activity in the absence 
of detergent (Tables 1, 3, and 5) caused by cocaine and norco-
caine may be manifestations of a reactive metabolite covalently 
binding to tissue macromolecules as reported by Evans and 
Harbison (1978). UDP-glucuronyl transferase is tightly bound 
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to ~he microsomal membrane (Dutton, 1971) and is not completely 
exposed on the surface of the endoplasmic reticulum (Hanninen, 
1974). Consequently, any perturbation of the membrane may 
cause an activation of this enzyme by exposing latent enzyme 
within the membrane. Covalent binding of cocaine or norcocaine 
to macromolecules in the endoplasmic reticulum may provide the 
necessary changes to activate UDP-g1ucurony1 transferase. Sim-
ilarly, the membrane perturbation may cause the inhibition of 
cytocnrome P-4S0-dependent oxidations, since this enzyme activ-
ity is known to be very dependent on the phospholipid environ-
ment (Strobel et a1., 1970; Chaplin and Mannering, 1970). The 
loss of cytochrome P-450 could also be due to changes in the 
rates of synthesis and breakdown. Denaturation of existing cy-
tochrome P-450 to cytochrome P-420 is also affected by the phos-
pholipid environment of the membrane (Omura and Sato, 1964b; Lu 
et a1., 1973), but no such conversion was apparent in our inves-
tigation. 
Evans and Harbison (1978) reported that phenobarbital in-
creased the cocaine-induced "delayed letha1ityll in mice. Con-
trary to this observation, phenobarbital decreased the changes 
in the microsomal and serum enzyme activities seen at 24 hr and 
5 days caused by cocaine and norcocaine. Although phenobarbi-
tal did not change the p~ttern of cocaine-induced increase in 
SGPT activity (Figure 12), this may, in fact, represent a de-
crease in SGPT release per gram of liver, because phenobarbital 
induction caused hepatocyte proliferation, which nearly doubled 
the liver mass. Accompanying the biochemical change was a 
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shift in the location of hepatocyte necrosis from midzonal to 
periportal areas. However, this shift did not alter the extent 
of diffuse necrosis (Figures l3A and l3B). The lack of change 
in the monooxygenase activities by cocaine or norcocaine with 
phenobarbital pretreatment may partially be explained by the 
observation in rats which indicates the cytochrome P-450 con-
tent is 50% lower in the periportal regions compared with cen-
tral regions (Gooding et al, 1978). Following phenobarbital 
pretreatment, this regional variation was increased to a 5-fold 
difference. These difference could alter the metabolic balance 
between oxidation and hydrolysis for these regions of the liver. 
In contrast to phenobarbital, 3-methylcholanthrene pretreat-
ment did not alter the biochemical parameters or zonal location 
of necrosis caused by cocaine and norcocaine toxicity. 
In summary, the cocaine- and norcocaine-induced hepato-
toxicity reported here results from their oxidative metabolism 
to a reactive intermediate and conjugative pathways involving 
GSH are important in detoxifying the reactive metabolite. 
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PART II 
THE METABOLISM OF COCAINE IN RATS AND MICE AND ITS 
POSSIBLE RELATIONSHIP TO HEPATOTOXICITY 
INTRODUCTION 
The occurrence of hepatotoxicity in mice has been observed 
for cocaine (Evans and Harbison, 1976, 1978; Evans et al., 1976; 
Freeman and Harbison, 1977, 1978; Jordan and Franklin, 1978; 
Jordan et al., 1979; Shuster et al., 1977) for norcocaine 
(Evans, 1979; Jordan et al., 1979). The mechanism of cocaine-
induced hepatotoxicity was postulated to involve the metabolic 
formation of a reactive intermediate, such as an N-oxide or an 
epoxide, which could covalently bind to cellular macromolecules 
(Evans and Harbison, 1978). Although rats are capable of N-
demethylating cocaine to norcocaine (Nayak et al., 1976; Englert 
et al., 1976; Leighty and Fentiman, 1974; Misra et al., 1974; 
Ramos-Aliago and Chiriboga, 1970; and Stewart et al., 1978) and 
possibly of hydroxylating the pyrolidine and benzyl rings of co-
caine (Nayak et al., 1976), no hepatotoxicity in this species 
has been reported, even with doses as high as 200 mg/kg (Misra 
et al., 1975). 
Relatively little is known about the in vitro metabolism 
of cocaine in microsomes from rats and mice, even though the oxi-
dative enzymes present in the microsomes are those which are 
postulated to activate cocaine to a reactive intermediate and 
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produce hepatotoxicity in mice. Both rats and mice N-demethy-
late cocaine at approximately the same rate in liver homogen-
ates, based on the formation of formaldehyde (Ramos-Aliago and 
Chiriboga, 1970). Rat microsomes were capable of producing 
benzoylecgonine, norcocaine, and benzoy1norecgonine (Leighty and 
Fentiman, 1974; Estevez et a1o, 1977), and the amounts of in 
vitro hydrolysis were twice those of methylation. However, in 
isolated rat hepatocytes the N-demethy1ation of cocaine only 
accounted for approximately 20% of the total cocaine metabolized 
(Stewart et al., 1978). SKF 525-A (2-diethy1aminoethyl-2,2-
dipheny1valerate:HC1) was observed to inhibit the ~ vitro pro-
duction of norcocaine and benzoy1norecgonine by as much as 67% 
(Estevez et al., 1977). 
Because of the species difference in suscept-ibility to 
cocaine-induced hepatotoxicity, it was considered important to 
examine the pattern of in vitro metabolism of cocaine in rats 
and mice and the effects of altering the microsomal drug metab-
olizing capability on cocaine metabolism. Phenobarbital induc-
tion of the microsomal drug metabolizing enzymes in mice is 
known to increase their susceptibility to acetaminophen-induced 
liver necrosis (Mitchell et al., 1973). In contrast to pheno-
barbital, 3-methylcholanthrene induction alters the microsomal 
drug metabolizing systems, but does not, in general, increase 
the toxicity and, in fact, may decrease the hepatotoxicity by 
increasing alternate nontoxic and detoxification pathways 
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(Zampaglione et al., 1973). The pattern of cocaine metabolism 
in these species and the difference in susceptibility to hepato-
toxicity may be related, implicating a specific metabolic path-
way for the activation of cocaine, as opposed to its detoxica-
tion. 
METHODS 
Animals and Treatment 
Male outbred albino mice, CFl strain, 8 to 9 weeks old 
(25-30 g) were obtained from Charles River's Laboratory (Wil-
mington, Massachusetts). Male Sprague-Dawley rats (170-200 g) 
were obtained from Simonsen Laboratories (Gilroy, California). 
Animals were housed under controlled conditions on a 12 hr 
light/dark cycle, with free access to water and food (S/L custom 
lab diet, G4.5, Simonsen Laboratories, Inc., Gilroy, California) 
at least one week prior to use. All drugs were dissolved in 
saline anq filtered through a 0.2 ~m Millipore filter unless 
otherwise indicated, and administered ip in a constant volume 
of 0.1 ml/10 g for mice and 1.0 ml/kg for rats. Pretreated 
animals received phenobarbital (80 mg/kg) for 4 days, 3-
methyl cholanthrene (20 mg/kg) in corn oil for 3 days, or diethyl 
maleate (0.6 ml/kg) in corn oil 30 min prior to cocaine or nor-
cocaine treatment. 
Instruments 
A Hewlett-Packard Model 57l0A equipped with dual flame 
ionization detector gas-liquid chromatograph (GLC) was used. 
Glass columns (2 mm x 1.9 m) were packed with 3% OV-17 on 
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Gas~Chrom Q 80/100 mesh. The o~en temperature was maintained at 
220 0 C and the injection port and detector at 300 0 C. The car-
rier gas was helium at a flow rate of 30 ml/min and the flame 
gases were hydrogen (30 ml/min) and air (240 ml/min). All spec-
trophotometric detenninations of microsomes were performed with 
a temperature-regulated (25 0 C) Aminco m~-2 spectrophotometer. 
Preparation of Benzoylecgonine 
and Norcocaine 
Benzoylecgonine (BE) was prepared from cocaine by modify-
ing the procedure of Findlay (1954). Cocaine-HCL (3.2 g) was 
dissolved in water (30 ml) and the pH was adjusted to approxi-
mately 9 with NaOH. The cocaine was extracted with chloroform-
isopropyl alcohol, 80:20 (3 x 100 ml). The combined extracts 
were filtered and dried over CaC12 and evaporated to dryness. 
The residue was dissolved in water (20 ml), refluxed (8-10 hr), 
cooled to room temperature, and extracted with diethyl ether 
(2 x 50 ml) to remove any unreacted cocaine. After crystalliza-
tion at 40 C overnight, BE was collected by filtration and dried 
at 37 0 C. The crystalline product was examined for purity by 
GLC analysis. BE (1 mg) was dissolved in DMF (100 ~l) and a por-
tion mixed with an equal volume of derivatizing agent (DMF-
dipropyl or DMF-diisopropyl acetal). These DMF-dialkyl acetals 
allowed on-column derivatization of BE to propyl-BE or isopropyl-
BE, as described by Jain et ale (1977). The derivatives of BE 
can be separated from cocaine and norcocaine as seen by their 
80 
chromatographic profile (Figure 1). Underivatized BE was not 
detected, and derivatized BE only produced one peak, correspond-
ing to either propyl or isopropyl-BE. 
Norcocaine was prepared according to the procedure of 
Borne et a1. (1977) with the following modifications. Cocaine-
HC1 (5 g) dissolved in water (40 m1) was neutralized with NH40H 
(pH> 9.0) and extracted with chloroform-isopropyl alcohol and 
dried as described for BE. The cocaine was then used to pre-
pare norcocaine. The final product, an oily residue, was re-
crystallized fron1 heptane and analyzed by GLC-mass spectroscopy 
using chemi.cal ionization. All major fragmentation ions corres-
ponded to those observed by Leighty and Fentiman (1974) with the 
protonated molecular ion at m/e 290. The purity and overall 
yield was determined to be 93% and 40%, respectively. 
Microsomal and Enzymatic 
Determinations 
Hepatic microsomes were prepared according to the procedure 
described by Franklin and Estabrook (1971) and protein concentra-
tions were determined by the Biuret reaction (Gornall et al., 
1949). Spectral studies were performed with microsomes sus-
pended at 2 mg of protein per ml in 50 mM Tris-chloride buffer 
solution (pH 7.4) containing 150 mM KCl and 10 mM MgC12' Cyto-
chrome P-450 content was measured by the method described by 
Omura and Sato (1964), norbenzphetamine MI complex formation 
with cytochrome P-450 by the procedure of Franklin (1974a), and 
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FIGURE 1 
Separation of cocaine and its metabolites (norcocaine and 
benzoyl ecgonine) by GLC from microsomal assay mixtures as des-
cribed in "Methods." Benzoyl ecgonine was measured as the propyl 
derivative and isopropyl benzoyl ecgonine was used as the internal 














NAD~H-cytochrome £ reductase by the method described by Masters 
et a1. (1971). The dealkylation of ethylmorphine, cocaine and 
BE was determined by the production of formaldehyde (Nash, 
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1953), and p-nitroanisole by the fonnation of p-nitrophenol 
(Netter and Siedel, 1964). Uridine 51-diphospho (UDP)-glucuronyl 
transferase activity was measured by the rate of conjugation of 
p-nitrophenol with glucuronic acid in 50 mM Tris-chloride buffer 
(pH 7.85), containing 150 mM KC1, 10 mM MgC12' 100 l1m p-nitro-
phenol, and 2.5 mM UDP-glucuronic acid {Franklin, 1974b) in the 
presence and absence of a low concentration (0.05%) of nonionic 
detergent, Triton X-100 (Lueders and Kuff, 1967). Microsomal 
cocaine metabolism was measured in 50 mM Tris-chloride buffer 
solution (pH 7.4) containing 10 mM MgC1 2, and 150 mM KC1, with 
3 mg of microsomal protein and 1.2 mM NADPH. The reaction was 
initiated by the addition of coca:ine and assay mixtures (final 
vol. 1 ml) were incubated for 10 min at 25° C~ The microsomal 
assay mixtures were extracted with 5 ml of chloroform-isopropyl 
alcohol (80:20) following the addition of saturating amounts of 
sodium chloride and an internal standard (isopropyl-BE). The 
organic phase was evaporated, DMF (100 l1l) added to suspend the 
residue from each incubation mixture, and then DMF-dipropyl ace-
tal (100 111) added. The sample was mixed and immediately ana-
lyzed by GLe. A typical chromatogram showing cocaine, its 
metabolites (norcccaine and BE), and the internal standard is 
seen in Figure 1. Norcoca;ne and benzoyl ecgonine were 
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detectable at 2 nmol/ml and 5 nmol/ml, respectively, in assay 
mixtures with a signal to noise ratio of at least 5:1, while co-
caine was detectable at 2 nmol/ml with a signal to noise ratio 
of 10: 1 . 
Serum glutamate-pyruvate transaminase (SGPT) was measured 
in serum obtained by cardiac puncture as described by Jordan 
eta 1. (19 79) for m ice 0 r by de cap i ta t i on and b 1 e e din g rats. 
Chemicals 
NADPH, cytochrome c reductase (Type VI), UDP-glucuronic 
acid, sodium isocitrate, isocitrate dehydrogenase (Type VI), 
bovine serum albumin, and 3-methylcholanthrene were obtained 
from Sigma Chemical Co. (St. Louis, Missouri); phenobarbital and 
ethylmorphine were obtained from Mallinckrodt Chemical Works 
(St. Louis, Missouri); SKF 525-A:HCl from -Smith Kline & French 
Laboratories (Philadelphia, Pennsylvania); norbenzphetamine:HCl 
(N-benzyl-a-methylphenethyltamine:HC1) from Upjohn Co. (Kalama-
zoo, Michigan); p-nitroanisole and Triton X-100 from J.T. Baker 
Co. (Phillpsburg, New Jersey); diethyl maleate (80%), 2,2,2-
trichloroethylchloroformate, dimethylformide (DMF), DMF-dipro-
pylacetal, and DMF-diisopropyl acetal from Aldrich Chemical Co. 
(Milwaukee, Wisconsin); and p-nitrophenol from Eastman Organic 
Chemicals (Rochester, New York). SGPT stat-packs were pur-
chased from Calbiochem (La Jolla, California, and cocaine:HCl 
was obtained from Merck and Co., Inc. (Rahway, New Jersey). 
RESULTS 
Cocaine and norcocaine hepatotoxicity in mice caused a de-
crease in microsomal enzyme activities and an increase in SGPT 
activity. The possible hepatotoxic effects of cocaine and nor-
cocaine based on changes in these parameters were investigated 
in untreated and phenobarbital-pretreated rats (Table 1). 
Neither cocaine or norcocaine treatment altered the microsomal 
oxidative drug metabolizing parameters. The UDP-glucuronyl 
transferase activity was only altered at the higher doses of co-
caine and norcocaine, where a decrease in the total activity 
occurred. Cons is tent wi th the 1 ack of c ha'nge in mos t of the 
microsomal enzymes, no change was observed in SGPT activity by 
any of the treatments. Pretreatment with phenobarbital prior 
to cocaine administration did not produce hepatotoxic effects, 
even though the microsomal oxidative drug metabolizing capabil-
ity was significantly increased. However, conjugative activity 
was also increased by phenobarbital. Liver pathology was ex-
amined in at least 2 rats following each treatment, and no ob-
servable changes occurred based on light microscopic analysis. 
Cocaine metabolism in microsomes from untreated and pheno-

























































































































































































































































































































































































































































































































































































































































































measured to determine its possible relationship with hepatotox-
icity. The changes in hepatic drug metabolizing capability of 
the microsomes used for cocaine metabolism studies resulting from 
phenobarbita~ and 3-methylcholanthrene pretreatments are shown 
in Table 2. NADPH-cytochrome ~ reductase activity was increased 
(60%) by phenobarbital pretreatment but not by 3-methylcholan-
threne. Cytochrome P-450 content was also increased in both 
rats (100%) and mice (60%) with phenobarbital pretreatment, and 
to a lesser extent with 3-methylcholanthrene (60% and 10%, re-
spectively). Both p-nitroanisole O-demethylase and ethylmor-
phine N-demethylase activities showed similar increases for rats 
(5.5- and 2.5-fold, respectively) and mice (2.l- and 1.8-fold, 
respectively) with phenobarbital pretreatment, but little or no 
increase with 3-methylcholanthrene, especially for ethylmorphine 
N-demethylation. The changes in the rate of norbenzphetamine MI 
complex formation was in agreement with previously reported data 
(Franklin, 1978), which showed marked increases following pheno-
barbital induction of cytochrome P-450. 
The effects of these inducers on microsomal cocaine metabo-
lism in rats and mice at concentrations which approximate theo-
retical uniform body distribution of ~ vivo dosages are shown 
in Tables 3 and 4. In rats (Table 3), phenobarbital and 3-
methyl cholanthrene pretreatment did not alter the amounts of BE 
or norcocaine produced, except for a slight increase (10-15%) by 


























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Und~r the microsomal assay condltions, some of the initial co-
caine was metabolized to products ("unidentified metabolites ll ), 
which were not quantitated by the analytical procedure and not 
accounted for by norcocaine and benzoyl ecgonine, and this amount 
was unchanged by the inducers, except for one spurious result 
(400 ~M cocaine with phenobarbital-pretreated rat microsomes). 
The total amount of cocaine metabolized was increased by about 
10% with phenobarbital pretreatment, but not by 3-methylcholan-
threne. In general, the amounts of the hydrolytic product (BE) 
were 5- to 6-fold greater than the amounts of the oxidative 
product (norcocaine). The metabolism of cocaine in mice and the 
effects of induction are shown in Table 4. The amounts of BE 
produced were approximately one-quarter of that produced in rats 
for lower cocaine concentrations (50 and 100 ~M) in standard 
assay mixtures and one-half for hJgher concentrations (200 and 
400 ~M). Like rats, neither phenobarbital or" 3-methylcholan-
threne pretreatment dramatically altered BE formation. Norco-
caine production was similar for untreated rats and mice, while 
phenobarbital pretreatment in mice caused a decrease compared 
with little or no change in rats. Pretreatment with 3-methyl-
cholanthrene as in rats did not alter the amounts of norcocaine 
formed. The decrease in norcocaine produced in mice with pheno-
barbital pretreatment was accompanied by a large increase in the 
amounts of unidentified metabolites. The amounts of unidenti-
fied metabolites, except for one odd result (400 ~M cocaine), 
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were not changed by 3-methylcholanthrene pretreatment. As in 
rats, the overall amounts of cocaine metabolized were increased 
(25-50%) by phenobarbital pretreatment, but not generally by 3-
methylcholanthrene. Thus, the two species showed differences in 
their ~ vitro cocaine metabolism which might be related to the 
pattern of hepatotoxicity, but the lower percent of oxidative 
metabolism in rats could not be manipulated by induction to 
equal that of mice. 
To further investigate the possible relationship of ~ 
vitro cocaine metabolism to hepatotoxicity, the kinetics of co-
caine N-demethylation was examined, because this metabolic route 
was postulated (Evans and Harbison, 1978) as important for the 
activation of cocaine to a reactive intermediate. The rates of 
cocaine N-demethylation by microsomes from untreated and 
phenobarbital-pretreated mice at various cocaine concentrations 
are shown in Figure 2. The reaction was followed by the amounts 
of formaldehyde produced. Both microsomes from untreated and 
phenobarbital-pretreated mice showed non-Michaelis-Menten kinet-
ics, although additional determinations, particularly at higher 
cocaine concentrations, would be necessary to accurately calcu-
late the Km values for the different components of the reaction. 
Phenobarbital pretreatment caused an increase in the rate of N-
demethylation of cocaine based on the formaldehyde produced 
(Figure 2), which contrasts with the decreased amounts of nor-
cocaine formed (Table 2). Because of the differences in 
93 
FIGURE 2 
Cocaine N-demethylation in microsomes from untreated and 
phenobarbital-pretreated mice. The standard assay conditions 
were described in "Methods," with the cocaine concentration var-
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nor~ocaine and formaldehyde production, the N-demethylation of BE 
in microsomes from untreated and phenobarbital-pretreated mice 
and rats was investigated. Neither microsomes from untreated or 
phenobarbital-pretreated rats could N-demethylate BE based on 
the production of formaldehyde. Only microsomes from 
phenobarbital-pretreated mice could N-demethylate BE, but the 
rate was approximately 4% of that of cocaine (0.12 vs. 3.34 
nmol/min/mg) using 2 mM substrate concentrations. Therefore, 
the N~demethylation of BE would not significantly contribute to 
the amounts of formaldehyde measured during cocaine N-demethyla-
tion, which was nearly doubled in mice pretreated with pheno-
barbi ta 1 . 
Because of the nonlinear Lineweaver-Burk plot (Figure 2) 
and the postulated importance of cocaine N-demethylation in 
forming a" reactive metabolite, the affinities of cocaine and nor-
cocaine for the demethylating enzyme system were indirectly ex-
amined in microsomes from rats and mice. Relatively low concen-
trations of nitroanisole, a competitive substrate, were used to 
avoid a component of the demethylation reaction with a high Km. 
Such a component may contribute to the nonlinearity of the reac-
tion as suggested by Stewart et al. (1978) for isolated rat he-
patocytes. The relative affinities of cocaine, norcocaine, and 
SKF 525-A, for the enzyme catalyzing the demethylation of p-
nitroanisole for mice were estimated by the Ki values (660, 290, 
and 45 ~M, respectively) as seen in Figure 3. Both cocaine and 
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FIGURE 3 
Cocaine, norcocaine, and SKF 525-A inhibition of p-
nitroaniso1e O-demethy1ation in microsomes from untreated mice. 
The concentrations of p-nitroanisolewere varied in the assay 
mixture from 0.025 mM to 1.0 mM. 
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norcocaine had a lower affinity for the enzyme than SKF 525-A, 
but the Ki for norcocaine was less than the Ki for cocaine. Sim-
ilar studies with rat microsomes (Figure 4) showed that, like 
mice, the affinities of cocaine and norcocaine were much lower 
than for SKF 525-A (Ki, 18 ~). However, in this species, co-
caine had a greater affinity than norcocaine for the enzyme, 
based on the Ki values (390 and 600 ~M, respectively). Both 
cocaine and norcocaine interact with cytochrome P-450 in a man-
ner characteristic of substrates, forming Type I binding spectra, 
but the relative affinities based upon spectral binding constants 
were difficult to ascertain because the Type I binding spectra of 
norcocaine was somewhat obscured by an amine Type II spectral in-
teraction, especially at higher substrate concentrations. 
Alterations in microsomal drug metabolizing capability by 
phenobarbital induction (Table 1) did not cause cocaine to be-
come hepatotoxic in rats, nor did it dramatically change the ~ 
vitro metabolism of cocaine (Table 3). If a toxic intermediate 
is formed in rats, as mice, then the balance between formation of 
the reactive species and its detoxication may be different. The 
effects of depleting GSH by diethyl maleate on cocaine- and 
norcocaine-induced hepatotoxicity in rats are seen in Table 5. 
The most pronounced changes occurred in SGPT activity where both 
cocaine and norcocaine treatment caused a dose-dependent in-
crease after diethyl maleate pretreatment (3- to 4-fold at 40 
mg/kg; 7-fold at 60 mg/kg). This increase in SGPT activity did 
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FIGURE 4 
Cocaine, norcocaine, and SKF 525-A inhibition of p-
nitroanisole O-demethylation in microsomes from untreated rats. 
The concentrations of p-nitroanisole were varied in the assay 
mixture from 0.025 mM to 1.0 mM. 
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not normally occur with cocaine or norcocaine (Table 1). 
Phenobarbital-pretreated animals receiving diethyl maleate before 
cocaine also showed an increase in SGPT activity (9-fold), sim-
ilar to that seen in the absence of induction. 
Following diethy1 maleate treatment, the oxidative drug 
metabolizing parameters were decreased by cocaine and norcocaine. 
Cytochrome P-450 concentration was decreased 25% and p-nitroani-
sole O-demethylation was decreased by 45%. UDP-glucuronyl trans-
ferase activities, both in the presence (total) or absence (ac-
tive) of detergent, were slightly decreased by cocaine, and more 
so by norcocaine. This change was different from that observed 
for mice (Jordan et al., 1979), where the cocaine treatment ap-
peared to activate some of the latent microsomal UDP-glucurony1 
transferase and decrease the total activity, although it should 
be noted that the total activity present in the microsomal mem-
brane from rats is only about 25% of untreated mice. The de-
crease in total UDP-glucuronyl transferase activity caused by 
cocaine and norcocaine in untreated rats (Table 1) was not al-
tered by prior diethyl maleate treatment. 
Phenobarbital induction prior to diethy1 maleate did not, 
in general, potentiate the decrease in the microsomal parameters 
seen in uninduced animals after cocaine and diethyl maleate. The 
decrease in cytochrome P-450 content changed from 22% to 36%, and 
in p-nitroanisole O-demethy1ation from 52% to 21%. The total 
UDP-g1ucuronyl transferase activity was markedly increased 
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(2.~-fold) by phenobarbital induction and, in contrast to unin-
duced rats receiving diethyl maleate, cocaine was able to acti-
vate some of the latent UDP-glucuronyl transferase activity 
after phenobarbital pretreatment. The reason for the slight in-
crease in total UDP-glucuronyl transferase by cocaine in rats 
under these conditions is obscure. 
Changes in the microsomal and serum enzyme activities 
caused by cocaine and norcoca;ne after diethyl maleate treatment 
in rats are consistent with the liver pathology (Figure 5). 
Cocaine-induced liver necrosis developed in rats treated with 
.diethyl maleate (Figure 5A). A foci of degenerating hepatocytes 
were near the central vein and extended into the midzonal region. 
Acute and chronic inflammatory cells appeared around the central 
vein. Norcocaine also induced hepatocyte necrosis after diethyl 
maleate treatment (Figure 5B--nec!otic areas appear along the 
lower border). The necrosis around the central vein in rats con-
trasts with the sparing of this region from necrotic changes in 
mice. After phenobarbital and diethyl maleate pretreatment, co-
caine clearly caused diffuse midzonal necrosis (Figure 5C). An 
area of degenerating hepatocytes was seen between a central vein 
and portal tract. There was no marked increase of inflammatory 
cells. This midzonal lesion seen in rats caused by cocaine af-
ter phenobarbital and diethyl maleate pretreatment differed from 
that seen in mice with a similar treatment, where it was predom-
inantly periportal (Jordan et al., 1979). 
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FIGURE 5 
Coca i ne- and norcoca i ne- induced hepa tocyte necros is in ra ts. 
Animals were given diethyl maleate (0.6 ml/kg) in corn oil 30 
min prior to cocaine (Panel A) and norcocaine (Panel B) adminis-
tration at 40 mg/kg. H & E x 200. Animals were pretreated with 
phenobarbital (80 mg/kg) for 4 days before diethyl maleate 
(0.6 mg/kg) and cocaine (60 mg/kg) administration (Panel C). 





The oxidative metabolism of cocaine and norcocaine is 
necessary to activate them to hepatotoxic intermediates in mice 
(Jordan et al., 1979). However, in rats treated with comparable 
doses of cocaine or norcocaine, neither produced hepatotoxic 
changes in the microsomal and serum enzyme activities (Table 1). 
This was consistent with the absence of hepatocyte necrosis as 
seen by histopathologic examination. The different susceptibil-
ity of these species to cocaine and norcocaine hepatotoxicity 
may be related to differences in their pattern of cocaine metab-
olism, anq a balance between oxidative and hydrolytic pathways. 
In comparing the microsomal cocaine metabolism of rats 
and mice, the extent of formation of hydrolytic product, benzoyl-
ecgonine, was much greater in rats than mice and not affected by 
induction with phenobarbital or 3-methylcholanthrene. In both 
rats and mice, the amounts of norcocaine formed were similar. 
Norcocaine accumulation was decreased significantly in mice by 
phenobarbital pretreatment, while little or no change occurred 
with rats. In addition to the measured metabolites, the amounts 
of "unidentified metabolites ll in both untreated and induced ani-
mals were greater for mice than rats at similar cocaine concen-
trations. Phenobarbital pretreatment in mice increased these 
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amounts but not in rats. This pattern of cocaine metabolism 
appeared rather unusual, since phenobarbital induction did not 
increase oxidative metabolism to norcocaine, like other sub-
strates of cytochrome P-450. However, the difference in the pat-
tern of cocaine metabolism may be related to the differences in 
the relative amounts of forms of cytochrome P-450 in the two 
species following phenobarbital induction. Rats showed 6 dif-
ferent forms of cytochrome P-450 (Thomas et al., 1976), while 
mice showed only 4 after phenobarbital induction (Huang et al., 
1976). Pretreatment with 3-methylcho1anthrene,which is known to 
induce a different form of cytochrome P-450 (P-448) with its own 
substrate specificities, caused no change. The overall amounts 
of cocaine metabol ized were greater in rats than mice, and pheno-
barbital pretreatment increased these amounts, although not 
dramatically, while 3-methylcholanthrene pretreatment caused no 
change. The two species showed different patterns of ~ vitro 
cocaine metabolism, which may be related to the formation of' the 
hepatotoxicity active metabolite, although other metabolic path-
ways, not measured, such as ring hydroxylation, could be impor-
tant in metabolically activating cocaine to a reactive metabolite. 
However, not only would the metabolic activation be important in 
producing the hepatotoxicity but also the balance between this 
and detoxication pathways, such as conjugation and hydrolysis, 
would be important in the specie susceptibility to toxicity. In 
rats, as with mice, the cytochrome P-450-dependent oxidative 
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rou~es involving dealkylation and hydroxylation of cocaine and 
norcocaine could be important in the production of a reactive 
intermediate, which would be subsequently detoxified in rats but 
not in mice. Both mice microsomes (Figure 2) and rat hepatocytes 
(Stewart et al., 1978) did not obey Michaelis-Menten kinetics 
for ,the N-demethylation of cocaine. This deviation from 
Michaelis-Menten kinetics is not peculiar to cocaine. It has 
been observed for the microsomal N-demethylation of aminopyrine 
with rat (Matsubsra and Touchi, 1977) and goat (Pederson and 
Aust, 1970). It has been suggested that this type of kinetics 
occurs because more than one N-demethylating reaction, with dif-
ferent Km's, contribute to the formation of products (Stewart 
et al., 1978). The rate of N-dealkylation of cocaine measured 
by formaldehyde production was increased by phenobarbital pre-
treatment in mice (Figure 2) and was inhibited, as expected, by 
SKF 525-A (not shown). The phenobarbital stimulation of cocaine 
metabolism measured as formaldehyde differed from the amounts of 
norcocaine produced (Table 4). Although not measured, benzoyl-
norecgonine from the hydrolysis of norcocaine which would be re-
flected as an increase in the amounts of unidentified metabo-
lites could partially account for this. The combined amounts of 
norcocaine and "unidentified metabolites" increased 2-fold with 
phenobarbital induction, like the 2-fold increase in formaldehyde 
production. Also, this decrease of norcocaine but increase in 
formaldehyde may suggest that norcocaine is further metabolized 
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pos~ibly to a hepatotoxic reactive intermediate. The increase in 
covalent binding of cocaine to tissue macromolecules that was ob-
served by Evans and Harbison (1978) supports this mechanism and 
would contribute to a decrease of norcocaine. If the decrease of 
norcocaine in mice with phenobarbital pretreatment represents 
further metabolism of norcocaine, as reflected by an increase of 
"unidentified metabolites"; then the increase in "delayed leth-
al i tyll (Evans and Harbison, 1976 and 1978) could be the resul t of 
norcocaine metabolic activation to a reactive intermediate. 
The increase in unidentified metabolites and decrease in 
norcocaine following induction with phenobarbital was not seen 
with rat microsomes, and no hepatotoxicity was observed. In 
addition to the formation of norcocaine by rats and mice micro-
somes (Tables 3 and 4), benzoyl ecgonine was produced in relative-
ly large amounts by both species, but twice as much in rats as 
mice. N-demethylation of benzoyl ecgonine to benzoylnorecgonine 
does not occur in significant amounts in either untreated or 
phenobarbital-pretreated rats or mice and,_ therefore, does not 
contribute to formaldehyde production in microsomal assay mix-
tures. 
Because of the postulated importance of the oxidative en-
zymes in cocaine demethylation and the formation of a hepato-
toxic reactive metabolite, the relative affinities of cocaine 
and norcocaine for these enzymes may be indicative of their 
ability to be metabolized. In mice, norcocaine apparently has 
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a greater affinity for the dealkylating enzyme than cocaine. In 
rats, it is the reverse. This difference could relate to the dif-
ference in the species to further metabolize norcocaine to a 
reactive intermediate in sufficient quantities to be hepatotoxic. 
The competitive inhibition of p-nitroanisole dealkylation indi-
rectly indicated that norcocaine can be further metabolized by 
oxidative enzyme systems. 
If the rate of formation of the hepatotoxic intermediate 
was slower in rats than mice, as indirectly indicated by the 
differing affinities of cocaine and norcocaine for the dealkylat-
ing enzymes, then the potential for formation of a hepatotoxic 
intermediate is greater in mice. Consequently, detoxication path-
ways, such as conjugation, may not be saturated in rats as com-
pared to mice. The liver GSH concentrations were an important 
determinant of the severity of the hepatotoxic effects of cocaine 
and norcocaine in mice (Evans and Harbison, 1978; Jordan and 
Franklin, 1979) and critically important in rats (Table 5). 
In summary, the specie difference in metabolism of cocaine 
was quantitative rather than qualitative, which would imply that 
detoxication mechanisms are important, especially in rats, in 
protecting the liver from hepatotoxicity. The effects of deplet-
ing GSH in rat livers caused the development of cocaine and nor-
cocaine hepatotoxicity, which was not normally seen with cocaine 
or norcocaine treatment in this species. 
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